Le Lézard
Classified in: Health
Subjects: TDS, FVT

BIOLASE Announces Participation At The Sidoti & Company Fall 2018 Investor Conference In New York City September 27, 2018


IRVINE, Calif., Sept. 19, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ CM:BIOL), the global leader in dental lasers, today announced John Beaver, Executive Vice President and Chief Financial Officer, is scheduled to present at the Sidoti & Company Fall 2018 Investor Conference at 10:55 am Eastern Time on Thursday, September 27.  He is also scheduled to participate in one-on-one meetings with investors during the Conference. The conference is being held at the Grand Hyatt in New York City.

BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.)

A live webcast and a 90-day replay of the presentation will be available on the BIOLASE Investor Events Page.

Mr. Beaver will also be available to participate in one-on-one meetings with investors in New York City on Wednesday, September 26.  To arrange a meeting, please contact Nathan Abler by e-mail at [email protected] or by phone at (714) 742-4180.

About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 244 patented and 74 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times.  BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients.  BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold over 37,600 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer markets.

For updates and information on Waterlase iPlus®, Waterlase Expresstm, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

 

SOURCE BIOLASE, Inc.


These press releases may also interest you

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...



News published on and distributed by: